We observed increased GranzymeB+Selplg-/- P14+ T cells after anti-PD-L1 treatment (Figure 6K), and no significant differences in tumor mass between IgG and anti-PD-L1 treated mice (Figure 6L). The gene discussed is SELPLG; the disease is neoplasm.